US equities |
NVDA $239.24 ▲+0.14% MU $1,045.56 ▼-1.73% SPCX $171.92 ▲+0.49% AMD $649.42 ▲+2.80% MRVL $287.01 ▲+5.81% AVGO $375.81 ▲+3.67% INTC $112.50 ▼-3.18% MSFT $529.30 ▲+0.78%
FinancialContent

Latest News about Psyence Biomedical

Recent news which mentions Psyence Biomedical

Psyence Biomedical Secures Extension To Meet Nasdaq Compliance Standards
Tickers NEWS PBM
Tags PBM Biotech Benzinga
From Benzinga
Psychedelic Biotech Psyence Grows Pipeline With Trials And Psilocybin Drug Developer Acquisition
Tickers NEWS OPTHF PBM
Tags OPTHF Clairvoyant Optimi Health Corp
From Benzinga
Psyence Biomed Launches First Trial Site In Australia For Phase IIb Psilocybin Study In Palliative Care
Tickers NEWS PBM
Tags Psychedelic Assisted Therapies Benzinga Psilocybin
From Benzinga